サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1768183

ヘルスケアにおける人工知能（AI）の世界市場

Artificial Intelligence (AI) in Healthcare

出版日
ページ情報
英文 183 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
ヘルスケアにおける人工知能（AI）の世界市場
出版日: 2025年07月11日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ヘルスケアにおける人工知能（AI）の世界市場、2030年までに3,465億米ドルに到達見込み

2024年に551億米ドルと推定されたヘルスケアにおける人工知能（AI）の世界市場は、2024年から2030年にかけてCAGR 35.8%で成長し、2030年には3,465億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるソフトウェアは、CAGR37.1％を記録し、分析期間終了時には1,772億米ドルに達すると予測されます。ハードウェア分野の成長率は、分析期間のCAGRで35.4％と推定されます。

米国市場は推定167億米ドル、中国はCAGR34.1％で成長予測

米国のヘルスケアにおける人工知能（AI）市場は2024年に167億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに498億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは34.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ32.0%と30.1%と予測されています。欧州では、ドイツがCAGR約24.6%で成長すると予測されています。

世界のヘルスケアにおける人工知能（AI）市場- 主要動向と促進要因まとめ

AIは診断精度と患者の転帰をどのように向上させているか？

人工知能（AI）はヘルスケアにおける診断に変革をもたらし、患者の転帰に大きな影響を与える、より迅速で正確な評価を可能にしています。従来、診断は臨床医の専門知識と経験に大きく依存していたが、現在ではAIが医療データと画像を迅速に分析することで、このプロセスを拡張し、人間によるミスの可能性を低減する精度を高めています。例えば、放射線科の機械学習アルゴリズムは、画像データをリアルタイムでスキャンすることで、がん、肺炎、心血管障害などの病気の初期徴候を検出することができ、多くの場合、症状が現れる前に問題を特定することができます。Zebra Medical VisionやAidocのような企業は、ディープラーニングを採用してCTスキャン、MRI、X線を驚くほど正確に解釈し、放射線科医が情報に基づいた判断を迅速に下せるよう支援しています。さらに、AIモデルは電子カルテ（EHR）、検査結果、遺伝子情報を分析することで患者のリスクを予測し、病気の進行を追跡することで、医師に実用的な洞察を提供しています。より迅速な診断とより個別化された治療計画を可能にすることで、AI主導の診断は患者の転帰を改善し、入院期間を短縮し、より積極的なヘルスケア・アプローチへの道を開いています。

AIは個別化治療と創薬を変革できるか？

治療を個別化し、創薬を促進するAIの可能性は、Global Industry Analystsの患者ケアへのアプローチ方法を再定義しつつあります。急成長しているプレシジョン・メディシンは、AIを活用して、個人の遺伝的体質、ライフスタイル、特定の健康状態に合わせて治療計画をカスタマイズする分野です。遺伝子情報、ライフスタイル要因、過去の健康記録を含む複雑なデータセットを分析することで、AIアルゴリズムは高度に個別化された治療を提案し、治療効果を最適化し、副作用を軽減することができます。例えば、IBMのワトソン・フォー・オンコロジーは、AIを使って個々の患者データと膨大な医学文献のライブラリに基づいてがん治療の選択肢を提案し、腫瘍医が十分な情報を得た上で意思決定できるようサポートします。創薬では、AIが潜在的な薬剤候補の特定を加速し、異なる分子がどのように相互作用するかを予測し、可能性のある副作用まで特定することで、従来の薬剤開発に関連する時間とコストを削減します。AtomwiseやBenevolentAIのようなAIプラットフォームは、ディープラーニングモデルを使って分子構造を解析し、かつては何年もかかっていた調査プロセスを迅速化します。個別化医療を強化し、創薬を迅速化することで、AIは治療法の開発と提供方法に革命をもたらし、最終的には、より効果的でタイムリーな医療ソリューションを通じて患者に利益をもたらしています。

AIはヘルスケアにおける業務効率化とリソース管理をどのように支援しているか？

AIは、ヘルスケア分野における業務効率とリソース管理の大幅な進歩を促進し、スタッフ不足、リソース配分、患者の待ち時間といった長年の問題に対処しています。病院やヘルスケアプロバイダーは、AIを活用した予測分析をスケジューリング、スタッフ配置、患者フローの管理に活用し、これらのプロセスを最適化することで、過密状態を解消し、リソースを効率的に使用できるようにしています。例えば、アルゴリズムは救急部門や診療所のピーク時間を予測し、より良い準備と人員配置の調整を可能にすることで、患者の待ち時間を最小限に抑えることができます。さらに、EHR管理におけるAIは、データ入力、請求処理、請求書作成などの反復的な管理業務を自動化し、ヘルスケアスタッフの管理負担を軽減し、全体的な効率を向上させる。バーチャルアシスタントやチャットボットは、患者からの問い合わせへの対応、予約のスケジューリング、患者への服薬のリマインドなど、業務負担をさらに軽減し、医療スタッフに負担をかけることなくサービスの質を高めています。AIは業務を効率化することで、ヘルスケアプロバイダーが患者の直接ケアにより集中できるようにし、効率を高め、最も必要なところにリソースを配置できるようにしています。

ヘルスケア市場におけるAIの成長を促す要因とは？

ヘルスケアにおけるAI市場の成長は、テクノロジーの進歩とヘルスケアニーズの進化がAIの採用を加速させるため、いくつかの重要な要因によって牽引されています。医療画像、遺伝子プロファイル、ウェアラブル健康機器から生成されるヘルスケアデータ量の増加により、これらの膨大なデータセットを理解することができるAI主導の分析が必要とされています。パーソナライズされたプロアクティブなヘルスケア・サービスに対する消費者の需要は、患者がオーダーメイドの治療計画や予防的ケアの選択肢を期待するようになっていることから、主要な促進要因となっています。自然言語処理とコンピュータ・ビジョンの技術的進歩により、医療データと言語ベースの健康情報を解釈するAIの能力が強化され、AIは診断、患者モニタリング、個別化医療に不可欠なものとなっています。さらに、量ベースのサービスよりも結果ベースの治療を重視する価値ベースの治療への世界のシフトは、診断精度の向上、治療計画の最適化、患者の転帰を予測するAIの能力と密接に一致しています。慢性疾患の増加により、患者のモニタリングと管理におけるAIソリューションの必要性はさらに高まっています。ヘルスケア技術に対する政府の取り組みと民間投資は、この分野の研究開発を加速させ、イノベーションを促し、ヘルスケアにおけるAIの応用を拡大しています。消費者の要望と、データ中心、効率的、患者中心のケアへの業界のシフトの両方に対応するためです。

セグメント

コンポーネント（ソフトウェア、ハードウェア、サービス）、テクノロジー（機械学習、自然言語処理、コンテクストアウェアコンピューティング、コンピュータビジョン）、用途（臨床試験、ロボットアシスタント手術、コネクテッドマシン、不正検出、診断、バーチャルアシスタント、投薬ミス削減、その他用途）、最終用途（病院・ヘルスケアプロバイダー、患者、製薬・バイオテクノロジー企業、ヘルスケアペイヤー、その他最終用途）

調査対象企業の例

  • Amazon Web Services（Aws）
  • Enlitic Inc.
  • General Electric Company
  • General Vision
  • Google
  • IBM Corporation
  • iCarbonX
  • Intel Corporation
  • Johnson & Johnson Services
  • Koninklijke Philips
  • Medtronic
  • Micron Technology
  • Microsoft Corporation
  • Next IT Corp.
  • Nvidia Corporation
  • Siemens Healthineers（A Strategic Unit Of Siemens Group）
  • Welltok Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP21181

Global Artificial Intelligence (AI) in Healthcare Market to Reach US$346.5 Billion by 2030

The global market for Artificial Intelligence (AI) in Healthcare estimated at US$55.1 Billion in the year 2024, is expected to reach US$346.5 Billion by 2030, growing at a CAGR of 35.8% over the analysis period 2024-2030. Software, one of the segments analyzed in the report, is expected to record a 37.1% CAGR and reach US$177.2 Billion by the end of the analysis period. Growth in the Hardware segment is estimated at 35.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$16.7 Billion While China is Forecast to Grow at 34.1% CAGR

The Artificial Intelligence (AI) in Healthcare market in the U.S. is estimated at US$16.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$49.8 Billion by the year 2030 trailing a CAGR of 34.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 32.0% and 30.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 24.6% CAGR.

Global Artificial Intelligence (AI) in Healthcare Market - Key Trends and Drivers Summarized

How Is AI Enhancing Diagnostic Accuracy and Patient Outcomes?

Artificial Intelligence (AI) is transforming diagnostics in healthcare, enabling faster, more accurate assessments that significantly impact patient outcomes. Traditionally, diagnoses relied heavily on a clinician’s expertise and experience, but AI now augments this process by rapidly analyzing medical data and imaging with a level of precision that reduces the likelihood of human error. Machine learning algorithms in radiology, for example, can detect early signs of diseases like cancer, pneumonia, and cardiovascular disorders by scanning imaging data in real time, often identifying issues before symptoms manifest. Companies like Zebra Medical Vision and Aidoc are employing deep learning to interpret CT scans, MRIs, and X-rays with remarkable accuracy, assisting radiologists in making informed decisions quickly. Furthermore, AI models predict patient risks and track disease progression by analyzing electronic health records (EHRs), laboratory results, and genetic information, providing doctors with actionable insights. By enabling faster diagnoses and more personalized treatment plans, AI-driven diagnostics are improving patient outcomes, reducing hospital stays, and paving the way for a more proactive healthcare approach.

Can AI Transform Personalized Treatment and Drug Discovery?

AI’s potential to individualize treatments and expedite drug discovery is redefining how we approach patient care. Precision medicine, a rapidly growing field, leverages AI to customize treatment plans tailored to an individual’s unique genetic makeup, lifestyle, and specific health conditions. By analyzing complex datasets that include genetic information, lifestyle factors, and previous health records, AI algorithms can suggest highly personalized therapies, optimizing treatment efficacy and reducing adverse reactions. IBM’s Watson for Oncology, for instance, uses AI to recommend cancer treatment options based on individual patient data and an extensive library of medical literature, supporting oncologists in making well-informed decisions. In drug discovery, AI accelerates the identification of potential drug candidates, predicting how different molecules might interact and even identifying possible side effects, reducing the time and costs associated with traditional drug development. AI platforms like Atomwise and BenevolentAI use deep learning models to analyze molecular structures, expediting the research process that once took years. By enhancing personalized care and fast-tracking drug discovery, AI is revolutionizing how treatments are developed and delivered, ultimately benefiting patients through more effective and timely medical solutions.

How Is AI Assisting in Operational Efficiency and Resource Management in Healthcare?

AI is driving significant advancements in operational efficiency and resource management within the healthcare sector, addressing longstanding issues like staff shortages, resource allocation, and patient wait times. Hospitals and healthcare providers are utilizing AI-driven predictive analytics to manage scheduling, staff allocation, and patient flow, optimizing these processes to reduce overcrowding and ensure that resources are used efficiently. For example, algorithms can predict peak times in emergency departments or clinics, allowing for better preparation and staffing adjustments, thereby minimizing patient wait times. Additionally, AI in EHR management automates repetitive administrative tasks such as data entry, claims processing, and billing, reducing the administrative burden on healthcare staff and improving overall efficiency. Virtual health assistants and chatbots are further alleviating workload by addressing patient queries, scheduling appointments, and reminding patients of medication, enhancing service quality without overwhelming healthcare personnel. By streamlining operations, AI enables healthcare providers to focus more on direct patient care, increasing efficiency and ensuring resources are deployed where they are most needed.

What Factors Are Driving the Growth of AI in the Healthcare Market?

The growth in the AI in healthcare market is driven by several key factors, as advancements in technology and evolving healthcare needs accelerate AI adoption. Increasing healthcare data volumes, generated from medical imaging, genetic profiles, and wearable health devices, necessitate AI-driven analytics capable of making sense of these massive datasets. Consumer demand for personalized and proactive healthcare services is a primary driver, as patients increasingly expect tailored treatment plans and preventive care options. Technological advancements in natural language processing and computer vision are enhancing AI’s capabilities in interpreting medical data and language-based health information, making AI indispensable for diagnostics, patient monitoring, and personalized medicine. Additionally, the global shift toward value-based care, which emphasizes outcome-driven treatments over volume-based services, aligns closely with AI’s ability to improve diagnostic accuracy, optimize treatment plans, and predict patient outcomes. The rising prevalence of chronic diseases has further increased the need for AI solutions in patient monitoring and management. Government initiatives and private-sector investments in health technology are accelerating research and development in this area, encouraging innovation and expanding AI applications in healthcare. Together, these drivers indicate a transformative period for AI in healthcare, as it responds to both consumer demands and the industry’s shift towards data-centric, efficient, and patient-focused care.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence (AI) in Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software, Hardware, Services); Technology (Machine Learning, Natural Language Processing, Context-Aware Computing, Computer Vision); Application (Clinical Trials, Robot-Assisted Surgery, Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications); End-Use (Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 222 Featured) -

  • Amazon Web Services (Aws)
  • Enlitic Inc.
  • General Electric Company
  • General Vision
  • Google
  • IBM Corporation
  • iCarbonX
  • Intel Corporation
  • Johnson & Johnson Services
  • Koninklijke Philips
  • Medtronic
  • Micron Technology
  • Microsoft Corporation
  • Next IT Corp.
  • Nvidia Corporation
  • Siemens Healthineers (A Strategic Unit Of Siemens Group)
  • Welltok Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Artificial Intelligence (AI) in Healthcare - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Personalized Patient Care Propels Growth of AI in Healthcare
    • Focus on Early Disease Detection and Prevention Drives Adoption of AI-Powered Diagnostic Tools
    • Here's How Predictive Analytics in AI Enhances Patient Care Pathways and Outcome Optimization
    • Advances in Medical Imaging and Computer Vision Boost Precision in AI-Driven Diagnostic Solutions
    • Rising Prevalence of Chronic Diseases Expands Market for AI-Powered Remote Monitoring Systems
    • Here's How Natural Language Processing in AI Improves Medical Record Analysis and Documentation
    • Increasing Utilization of AI for Accelerating Drug Discovery and Development Processes
    • Focus on Enhancing Resource Allocation Drives AI Adoption in Healthcare Workforce Management
    • Growing Demand for Telemedicine Expands the Scope of AI in Remote Patient Monitoring
    • Here's How AI in Genomics Supports Personalized Treatment Plans and Precision Medicine Initiatives
    • Advancements in AI-Driven Robotics Transform Surgical and Rehabilitation Practices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Healthcare Payers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Healthcare Payers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Hospitals & Healthcare Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Pharmaceuticals & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for Pharmaceuticals & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Machine Learning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World 6-Year Perspective for Machine Learning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Natural Language Processing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World 6-Year Perspective for Natural Language Processing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Context-Aware Computing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 22: World 6-Year Perspective for Context-Aware Computing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Computer Vision by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World 6-Year Perspective for Computer Vision by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 25: World Artificial Intelligence (AI) in Healthcare Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Connected Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Connected Machines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Fraud Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Fraud Detection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Virtual Assistants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World 6-Year Perspective for Virtual Assistants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 36: World Recent Past, Current & Future Analysis for Dosage Error Reduction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 37: World 6-Year Perspective for Dosage Error Reduction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Clinical Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 41: World 6-Year Perspective for Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 42: World Recent Past, Current & Future Analysis for Robot-Assisted Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 43: World 6-Year Perspective for Robot-Assisted Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 46: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: USA 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 48: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: USA 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • CANADA
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 54: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Canada 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 58: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Canada 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 64: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Japan 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 66: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Japan 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 70: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: China 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 72: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: China 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 82: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 84: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 88: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: France 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 90: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: France 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 94: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Germany 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 96: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Germany 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 100: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Germany 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • ITALY
    • TABLE 102: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Italy 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 106: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Italy 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 108: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Italy 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 112: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: UK 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 114: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: UK 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 118: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 120: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 124: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of Europe 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 126: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Asia-Pacific 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 130: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Asia-Pacific 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 132: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Asia-Pacific 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 136: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Rest of World 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2025 & 2030
    • TABLE 138: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Rest of World 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2025 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World 6-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2025 & 2030

IV. COMPETITION